Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
Experimental PVSRIPO oncolytic virus therapy of glioblastoma has shown long-term efficacy in a subset of patients. Here the authors engineer the virus to enable incorporation of tumor-specific antigens, and show proof-of-principle evidence that this modification increases anti-tumor immunity and ext...
Saved in:
Main Authors: | Mubeen M. Mosaheb, Elena Y. Dobrikova, Michael C. Brown, Yuanfan Yang, Jana Cable, Hideho Okada, Smita K. Nair, Darell D. Bigner, David M. Ashley, Matthias Gromeier |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/9ce93ce8bbd34e53a699a9500f6bbbbf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
by: Michael C. Brown, et al.
Published: (2021) -
EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
by: V. V. Kurilin, et al.
Published: (2021) -
HIV/SIV infection primes monocytes and dendritic cells for apoptosis.
by: Mireille Laforge, et al.
Published: (2011) -
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
by: Troels R Petersen, et al.
Published: (2011) -
Direct detection of polioviruses using a recombinant poliovirus receptor.
by: Nancy Gerloff, et al.
Published: (2021)